Skip to main content

Innovatrix Capital

Key facts

Cohort: Cohort 9, 2022

Focus in insurance value chain/workflow: Point of underwriting  

Specific lines of business supported: Corporate I Speciality 

Founded: 2021

Status: Operating, still in insurance

Company type: MGA (planned)

Head office: United Kingdom

Main global offices: United Kingdom

Locations served: Global

Employee count: 1-10


Innovatrix Capital aims to offer a parametric insurance product for the life sciences sector. The product will cover risks associated with clinical trial phase failure, to encourage investment in life sciences. 

Lab activity

Primary focus product area whilst in the Accelerator: Parametric I Life sciences

Innovatrix Capital joined the Lab at an early stage and were fortunate to receive strong feedback and validations from mentors. This led to Innovatrix Capital expanding their product offering from a fully parametric product, into 3 products: an indemnity product, a semi-parametric product, and parametric product.   

"Innovatrix entered the Lab with a solution for a significant protection gap. Assisted by great support from the Lab team, the programme provided us with unrivalled access to and insight from the Lloyd’s market that confirmed the viability of our innovative product."
Piers Clark, Co-Founder

Explore all our alumni

Learn about all our alumni who have take part in the Lloyd’s Lab Accelerator programme.